Skip to Content

UK Edition. Click here for US version.

LUSTRAL 50 MG FILM-COATED TABLETS

Active substance(s): SERTRALINE HYDROCHLORIDE

View full screen / Print PDF » Download PDF ⇩
Transcript
PATIENT INFORMATION LEAFLET

0043/0044
14.06.16[29]

Lustral® 50 mg film-coated tablets
Lustral® 100 mg film-coated tablets
(sertraline hydrochloride)
Read all of this leaflet carefully before you start taking this medicine
because it contains important information for you.
 Keep this leaflet. You may need to read it again.
 If you have any further questions, ask your doctor or pharmacist.
 This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if their signs of illness are the same as
yours.
 If you get any side effects talk to your doctor or pharmacist. This
includes any possible side effects not listed in this leaflet. See section
4.
This medicine is available using any of the above names but will be
referred to as Lustral throughout this leaflet.
What is in this leaflet:
1. What Lustral is and what it is used for.
2. What you need to know before you take Lustral.
3. How to take Lustral.
4. Possible side effects.
5. How to store Lustral.
6. Contents of the pack and other information.
1. What Lustral is and what it is used for
Lustral contains the active substance sertraline. Sertraline is one of a
group of medicines called Selective Serotonin Re-uptake Inhibitors
(SSRIs); these medicines are used to treat depression and/or anxiety
disorders.
Lustral can be used to treat:

 Depression and prevention of recurrence of depression (in adults).
 Social anxiety disorder (in adults).
 Post traumatic stress disorder (PTSD) (in adults).
 Panic disorder (in adults).
 Obsessive compulsive disorder (OCD) (in adults and children and
adolescents aged 6-17 years old).

Depression is a clinical illness with symptoms like feeling sad, unable to
sleep properly or to enjoy life as you used to.
OCD and Panic disorders are illnesses linked to anxiety with symptoms
like being constantly troubled by persistent ideas (obsessions) that make
you carry out repetitive rituals (compulsions).
PTSD is a condition that can occur after a very emotionally traumatic
experience, and has some symptoms that are similar to depression and
anxiety. Social anxiety disorder (social phobia) is an illness linked to
anxiety. It is characterised by feelings of intense anxiety or distress in
social situations (for example: talking to strangers, speaking in front of
groups of people, eating or drinking in front of others or worrying that you
might behave in an embarrassing manner).
Your doctor has decided that this medicine is suitable for treating your
illness.
You should ask your doctor if you are unsure why you have been given
Lustral.
2. What you need to know before you take Lustral
Do not take Lustral:
 If you are allergic to sertraline or any of the other ingredients of this
medicine (listed in section 6).
 If you are taking or have taken medicines called monoamine oxidase
inhibitors (MAOIs such as selegiline, moclobemide) or MAOI like drugs
(such as linezolid). If you stop treatment with sertraline, you must wait
until at least one week before you start treatment with a MAOI.
After stopping treatment with a MAOI, you must wait at least 2 weeks
before you can start treatment with sertraline.
 If you are taking another medicine called pimozide (a medicine for
mental disorders such as psychosis).
Warnings and precautions
Talk to your doctor or pharmacist before taking Lustral.
Medicines are not always suitable for everyone. Tell your doctor before
you take Lustral, if you suffer from or have suffered in the past from any
of the following conditions:
 If you have epilepsy (fit) or a history of seizures. If you have a fit
(seizure), contact your doctor immediately.
 If you have suffered from manic depressive illness (bipolar disorder) or
schizophrenia. If you have a manic episode, contact your doctor
immediately.
 If you have or have previously had thoughts of harming or killing
yourself (see below-Thoughts of suicide and worsening of your
depression or anxiety disorder).
 If you have Serotonin Syndrome. In rare cases this syndrome may
occur when you are taking certain medicines at the same time as
sertraline. (For symptoms, see section 4. Possible Side Effects). Your
doctor will have told you whether you have suffered from this in the
past.
 If you have low sodium level in your blood, since this can occur as a
result of treatment with Lustral. You should also tell your doctor if you
are taking certain medicines for hypertension, since these medicines
may also alter the sodium level in your blood.
 If you are elderly as you may be more at risk of having low sodium level
in your blood (see above).
 If you have liver disease; your doctor may decide that you should have
a lower dose of Lustral.
 If you have diabetes; your blood glucose levels may be altered due to
Lustral and your diabetes medicines may need to be adjusted.
 If you have suffered from bleeding disorders or have been taking
medicines which thin the blood (e.g. acetylsalicyclic acid (aspirin), or
warfarin) or may increase the risk of bleeding.
 If you are a child or adolescent under 18 years old.
Lustral should only be used to treat children and adolescents aged 6-17
years old, suffering from obsessive compulsive disorder (OCD). If you
are being treated for this disorder, your doctor will want to monitor you
closely (see below - Children and adolescents).
 If you are having electro-convulsive therapy (ECT).
 If you have eye problems, such as certain kinds of glaucoma (increased
pressure in the eye).
 If you have been told that you have an abnormality of your heart tracing
after an electrocardiogram (ECG) known as prolonged QT interval.

Restlessness/Akathisia:
The use of sertraline has been linked to a distressing restlessness and
need to move, often being unable to sit or stand still (akathisia). This is
most likely to occur during the first few weeks of treatment. Increasing the
dose may be harmful so if you develop such symptoms you should talk to
your doctor.
Withdrawal reactions:
Side effects relating to stopping treatment (withdrawal reactions) are
common, particularly if the treatment is stopped suddenly (see section 3 If
you stop taking Lustral and section 4 Possible side effects). The risk of
withdrawal symptoms depends on the length of treatment, dosage, and
the rate at which the dose is reduced. Generally, such symptoms are mild
to moderate. However, they can be serious in some patients.
They normally occur within the first few days after stopping treatment. In
general, such symptoms disappear on their own and wear off within 2
weeks. In some patients they may last longer (2-3 months or more).
When stopping treatment with sertraline it is recommended to reduce the
dose gradually over a period of several weeks or months, and you should
always discuss the best way of stopping treatment with your doctor.
Thoughts of suicide and worsening of your depression or anxiety
disorder:
If you are depressed and/or have anxiety disorders you can sometimes
have thoughts of harming or killing yourself.
These may be increased when first starting antidepressants, since these
medicines all take time to work, usually about two weeks but sometimes
longer.
You may be more likely to think like this:
 If you have previously had thoughts about killing or harming yourself.
 If you are a young adult. Information from clinical trials has shown an
increased risk of suicidal behaviour in adults aged less than 25 years
with psychiatric conditions who were treated with an antidepressant.
If you have thoughts of harming or killing yourself at any time, contact
your doctor or go to a hospital straight away.
You may find it helpful to tell a relative or close friend that you are
depressed or have an anxiety disorder, and ask them to read this leaflet.
You might ask them to tell you if they think your depression or anxiety is
getting worse, or if they are worried about changes in your behaviour.
Children and adolescents:
Sertraline should not usually be used in children and adolescents less
than 18 years old, except for patients with Obsessive Compulsive
Disorder (OCD). Patients under 18 have an increased risk of undesirable
effects, such as suicide attempt, thoughts of harming or killing themselves
(suicidal thoughts) and hostility (mainly aggressiveness, oppositional
behaviour and anger) when they are treated with this class of medicines.
Nevertheless, it is possible that your doctor decides to prescribe Lustral to
a patient under 18 if it is in the patient’s interest. If your doctor has
prescribed Lustral to you and you are less than 18 years old and you
want to discuss this, please contact him/her. Furthermore, if any of the
symptoms listed above appear or worsen while you are taking Lustral,
you should inform your doctor. Also, the long-term safety of Lustral in
regard to growth, maturation and learning (cognitive) and behavioural
development in this age group has not yet been demonstrated.
Other medicines and Lustral:
Tell your doctor or pharmacist if you are taking, have recently taken or
might take any other medicines.
Some medicines can affect the way Lustral works, or Lustral itself can
reduce the effectiveness of other medicines taken at the same time.
Taking Lustral together with the following medicines may cause serious
side effects:
 Medicines called monoamine oxidase inhibitors (MAOIs), like
moclobemide (to treat depression) and selegiline (to treat Parkinson’s
disease), the antibiotic linezolid and methylene blue (to treat high levels
of methaemoglobin in the blood). Do not use Lustral together with these
medicines.
 Medicines to treat mental disorders such as psychosis (pimozide).
Do not use Lustral together with pimozide.
Talk to your doctor if you are taking the following medicines:
 Herbal medicine containing St. John’s Wort (Hypericum perforatum).
The effects of St. John’s Wort may last for 1-2 weeks.
 Products containing the amino acid tryptophan.
 Medicines to treat severe pain (e.g. tramadol).
 Medicines used in anaesthesia or to treat chronic pain (fentanyl,
mivacurium and suxamethonium).
 Medicines to treat migraines (e.g. sumatriptan).
 Blood thinning medicine (warfarin).
 Medicines to treat pain/arthritis (Non steroidal anti-inflammatory drug
(NSAID) such as ibuprofen, acetylsalicylic acid (aspirin)).
 Sedatives (diazepam).
 Diuretics (also called ‘water’ tablets).
 Medicines to treat epilepsy (phenytoin, phenobarbital, carbamazepine).
 Medicines to treat diabetes (tolbutamide).
 Medicines to treat excessive stomach acid, ulcers and heartburn
(cimetidine, omeprazole, lanzoprazole, pantoprazole, rabeprazole).
 Medicines to treat mania and depression (lithium).
 Other medicines to treat depression (such as amitriptyline, nortriptyline,
nefazodone, fluoxetine, fluvoxamine).
 Medicines to treat schizophrenia and other mental disorders (such as
perphenazine, levomepromazine and olanzapine).
 Medicines used to treat high blood pressure, chest pain or regulate the
rate and rhythm of the heart (such as verapamil, diltiazem, flecainide,
propafenone).
 Medicines used to treat bacterial infections (such as rifampicin,
clarithromycin, telithromycin, erythromycin).
 Medicines used to treat fungal infections (such as ketoconazole,
itraconazole, posaconazole, voriconazole, fluconazole).
 Medicines used to treat HIV/AIDS and Hepatitis C (protease inhibitors
such as ritonavir, telaprevir).
 Medicines used to prevent nausea and vomiting after an operation or
chemotherapy (aprepitant).
 Medicines known to increase the risk of changes in the electrical activity
of the heart (e.g. some antipsychotics and antibiotics).
Lustral with food, drink and alcohol:
Lustral tablets can be taken with or without food.
Alcohol should be avoided whilst taking Lustral.
Sertraline should not be taken in combination with grapefruit juice, as this
may increase the level of sertraline in your body.

Pregnancy, breast-feeding and fertility:
If you are pregnant or breast-feeding, think you may be pregnant or are
planning to have a baby, ask your doctor or pharmacist for advice before
taking this medicine.
The safety of sertraline has not fully been established in pregnant women.
Sertraline will only be given to you when pregnant if your doctor considers
that the benefit for you is greater than any possible risk to the developing
baby. If you are a woman capable of having children you should use a
reliable method of contraception (such as the contraceptive pill), when
taking sertraline.
Make sure your midwife and/or doctor know you are on Lustral.
When taken during pregnancy, particularly in the last 3 months of
pregnancy, medicines like Lustral may increase the risk of a serious
condition in babies, called persistent pulmonary hypertension of the
newborn (PPHN), making the baby breathe faster and appear bluish.
These symptoms usually begin during the first 24 hours after the baby is
born. If this happens to your baby you should contact your midwife and/or
doctor immediately.
Your newborn baby might also have other conditions, which usually begin
during the first 24 hours after birth. Symptoms include:
 trouble with breathing,
 a blueish skin or being too hot or cold,
 blue lips,
 vomiting or not feeding properly,
 being very tired, not able to sleep or crying a lot,
 stiff or floppy muscles,
 tremors, jitters or fits,
 increased reflex reactions,
 irritability,
 low blood sugar.
If your baby has any of these symptoms when it is born, or you are
concerned about your baby’s health, contact your doctor or midwife who
will be able to advise you.
There is evidence that sertraline passes into human breast milk.
Sertraline should only be used in women during breast-feeding, if your
doctor considers that the benefit exceeds any possible risk to the baby.
Some medicines like sertraline may reduce the quality of sperm in animal
studies. Theoretically, this could affect fertility, but impact on human
fertility has not been observed as yet.
Driving and using machines:
Psychotropic drugs such as sertraline may influence your ability to drive or
use machines. You should therefore not drive or operate machinery, until
you know how this medication affects your ability to perform these activities.
3. How to take Lustral
Always take this medicine exactly as your doctor or pharmacist has told
you.
Check with your doctor or pharmacist if you are not sure.
The recommended dose is:
Adults:
Depression and Obsessive Compulsive Disorder
For depression and OCD, the usual effective dose is 50 mg/day. The
daily dose may be increased in 50 mg increments and at intervals of at
least one week over a period of weeks. The maximum recommended
dose is 200 mg/day.
Panic disorder, Social anxiety disorder and Post Traumatic Stress
Disorder:
For panic disorder, social anxiety disorder and post traumatic stress
disorder, treatment should be started at 25 mg/day, and increased to 50
mg/day after one week.
The daily dose then may be increased in 50 mg increments over a
period of weeks. The maximum recommended dose is 200 mg/day.
Use in children and adolescents:
Lustral must only be used to treat children and adolescents suffering from
OCD aged 6-17 years old.
Obsessive Compulsive Disorder:
Children aged 6 to 12: the recommended starting dose is 25 mg daily.
After one week, your doctor may increase this to 50 mg daily. The
maximum dose is 200 mg daily.
Adolescents aged 13 to 17: the recommended starting dose is 50 mg
daily.
The maximum dose is 200 mg daily.
If you have liver or kidney problems, please tell your doctor and follow the
doctor’s instructions.
Method of administration:
Lustral tablets may be taken with or without food.
Take your medication once daily either in the morning or evening.
Your doctor will advise you on how long to take this medication for. This
will depend on the nature of your illness and how well you are responding
to the treatment. It may take several weeks before your symptoms begin
to improve. Treatment of depression should usually continue for 6 months
after improvement.
If you take more Lustral than you should:
If you accidentally take too much Lustral contact your doctor at once or go
to the nearest hospital casualty department.
Always take the labelled medicine package with you, whether there is any
medication left or not.
Symptoms of overdose may include drowsiness, nausea and vomiting,
rapid heart rate, shaking, agitation, dizziness and in rare cases
unconsciousness.
If you forget to take Lustral:
Do not take a double dose to make up for a forgotten dose. If you forget
to take a dose, do not take the missed dose. Just take the next dose at
the right time.

If you stop taking Lustral:
Do not stop taking Lustral unless your doctor tells you to.
Your doctor will want to gradually reduce your dose of Lustral over
several weeks, before you finally stop taking this medicine. If you
suddenly stop taking this medicine you may experience side effects such
as dizziness, numbness, sleep disturbances, agitation or anxiety,
headaches, feeling sick, being sick and shaking. If you experience any of
these side effects, or any other side effects whilst stopping taking Lustral,
please speak to your doctor.
If you have any further questions on the use of this product, ask your
doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not
everybody gets them.
Nausea is the most common side effect. The side effects depend on the
dose and often disappear or lessen with continued treatment.
Tell your doctor immediately:
If you experience any of the following symptoms after taking this
medicine, these symptoms can be serious.
 If you develop a severe skin rash that causes blistering (erythema
multiforme), (this can affect the mouth and tongue). These may be
signs of a condition known as Stevens Johnson Syndrome, or Toxic
Epidermal Necrolysis (TEN). Your doctor will stop your treatment in
these cases.
 Allergic reaction or allergy, which may include symptoms such as an itchy
skin rash, breathing problems, wheezing, swollen eyelids, face or lips.
 If you experience agitation, confusion, diarrhoea, high temperature and
blood pressure, excessive sweating and rapid heartbeat. These are
symptoms of Serotonin Syndrome. In rare cases this syndrome may
occur when you are taking certain medicines at the same time as
sertraline. Your doctor may wish to stop your treatment.
 If you develop yellow skin and eyes which may mean liver damage.
 If you experience depressive symptoms with ideas of harming or killing
yourself (suicidal thoughts).
 If you start to get feelings of restlessness and are not able to sit or
stand still after you start to take Lustral.
You should tell your doctor if you start to feel restless.
 If you have a fit (seizure).
 If you have a manic episode (see section 2 “Warnings and
precautions”).
The following side effects were seen in clinical trials in adults.
Very common (may affect more than 1 in 10 people):
Insomnia, dizziness, sleepiness, headache, diarrhoea, feeling sick, dry
mouth, ejaculation failure, fatigue.
Common (may affect up to 1 in 10 people):

 Sore throat, anorexia, increased appetite,
 depression, feeling strange, nightmare, anxiety, agitation, nervousness,
decreased sexual interest, teeth grinding,

 numbness and tingling, shaking, muscle tense, abnormal taste, lack of







attention,
visual disturbance, ringing in ears,
palpitations, hot flush, yawning,
abdominal pain, vomiting, constipation, upset stomach, gas,
rash, increased sweating, muscle pain, erectile dysfunction, chest pain.
joint pain,
malaise.

Uncommon (may affect up to 1 in 100 people):

 Chest cold, runny nose,
 hypersensitivity,
 low thyroid hormones,
 hallucination, feeling too happy, lack of caring, thinking abnormal,
aggression,

 convulsion, involuntary muscle contractions, abnormal coordination,









moving a lot, amnesia, decreased feeling, speech disorder, dizziness
while standing up, passing out, migraine,
enlarged pupils,
ear pain, fast heartbeat, high blood pressure, flushing,
breathing difficulty, possible wheezing, shortness of breath, nose bleed,
inflammation of the oesophagus, difficulty swallowing, haemorrhoids,
increased saliva, tongue disorder, burping,
eye swelling, purple spots on skin, face oedema, hair loss, cold sweat,
dry skin, hives, itching,
osteoarthritis, muscular weakness, back pain, muscle twitching,
nighttime urination, unable to urinate, increase in urination, increase in
frequency of urination, problem urinating, urinary incontinence,
vaginal haemorrhage, sexual dysfunction, female sexual dysfunction,
menstrual irregularities, swelling in legs, chills, fever, weakness, thirst,
increase in liver enzyme levels, weight decreased, weight increased.

Rare (may affect up to 1 in 1,000 people):

 Intestine problem, ear infection, cancer, swollen glands, high
cholesterol, low blood sugar,

 physical symptoms due to stress or emotions, drug dependence,











psychotic disorder, paranoia, suicidal thoughts, sleep walking,
premature ejaculation,
severe allergic reaction,
coma, abnormal movements, difficulty moving, increased sensation,
sensory disturbance,
glaucoma, tear problem, spots in front of eyes, double vision, light hurts
eye, blood in the eye,
problems controlling blood sugar levels (diabetes),
heart attack, slow heart beat, heart problem, poor circulation of arms
and legs, closing up of throat, breathing fast, breathing slow, difficulty
talking, hiccups,
blood in stool, sore mouth, tongue ulceration, tooth disorder, tongue
problem, mouth ulceration, problems with liver function,
skin problem with blisters, hair rash, hair texture abnormal, skin odour
abnormal, bone disorder,
decreased urination, urinary hesitation, blood in urine,
excessive vaginal bleeding, dry vaginal area, red painful penis and
foreskin, genital discharge, prolonged erection, breast discharge,
hernia, drug tolerance decreased, difficulty walking, semen abnormal,
increase in blood cholesterol levels, injury, relaxation of blood vessels
procedure.

 Cases of suicidal ideation and suicidal behaviours have been
reported during sertraline therapy or early after treatment
discontinuation (see section 2.).

After marketing sertraline, the following side effects have been
reported:
 Decrease in white blood cells, decrease in clotting cells, endocrine
problem, low blood salt, increase in blood sugar levels,
 terrifying abnormal dreams, suicidal behaviour,
 muscular movement problems (such as moving a lot, tense muscles,
difficulty walking and stiffness, spasms and involuntary movements of
muscles), sudden severe headache (which may be a sign of a serious
condition known as Reversible Cerebral Vasoconstriction Syndrome
(RCVS)),
 vision abnormal, unequal sized pupils, bleeding problems (such as
stomach bleeding), progressive scarring of lung tissue (Interstitial Lung
Disease), pancreatitis, serious liver function problems, yellow skin and
eyes (jaundice),
 skin oedema, skin reaction to sun, muscle cramps, breast enlargement,
problems with clotting, abnormal laboratory tests, bedwetting.
 Light-headedness, fainting, or chest discomfort which could be signs of
changes in the electrical activity (seen on electrocardiogram) or
abnormal rhythm of the heart.
Additional side effects in children and adolescents
In clinical trials with children and adolescents, the side effects were
generally similar to adults (see above). The most common side effects in
children and adolescents were headache, insomnia, diarrhoea and feeling
sick.
Symptoms that can occur when treatment is discontinued
If you suddenly stop taking this medicine you may experience side effects
such as dizziness, numbness, sleep disturbances, agitation or anxiety,
headaches, feeling sick, being sick and shaking (see section 3. “If you
stop taking Lustral”).
An increased risk of bone fractures has been observed in patients taking
this type of medicines.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This
includes any possible side effects not listed in this leaflet. You can also
report side effects directly via the Yellow Card Scheme at:
www.mhra.gov.uk/yellowcard.
By reporting side effects, you can help provide more information on the
safety of this medicine.
5. How to store Lustral
Keep out of the sight and reach of children.
Do not store above 30oC.
Do not use Lustral after the expiry date which is stated on the pack. The
expiry date refers to the last day of that month.
Medicines should not be disposed of via wastewater or household waste.
Ask your pharmacist how to dispose of medicines no longer required.
These measures will help to protect the environment.
6. Contents of the pack and other information
What Lustral contains
The active substance is sertraline hydrochloride.
Lustral 50mg film-coated tablets contains 50mg of sertraline
(as hydrochloride)
Lustral 100mg film-coated tablets contains 100mg of sertraline
(as hydrochloride)
Other ingredients: calcium hydrogen phosphate, hydroxypropylcellulose,
hydroxypropylmethylcellulose, magnesium stearate, microcrystalline
cellulose, polyethylene glycol, polysorbate-80, sodium starch glycollate,
and titanium dioxide.
What Lustral looks like and contents of the pack
Lustral 50 mg film-coated tablets are white capsular shaped with the
markings “ZLT” AND “50” on one side and “Pfizer” on the other side.
Lustral 100 mg film-coated tablets are white capsular shaped with the
markings “ZLT” AND “100” on one side and “Pfizer” on the other side.
Each pack contains 30 tablets.
Manufacturer and Product Licence Holder
Manufactured by Farmasierra Manufacturing S.L., San Sebastian de los
Reyes, Madrid, Spain. Procured from within the EU and Repackaged by
the Product Licence holder P.I.E. Pharma Ltd, 207 Kenton Road, Harrow,
Middlesex HA3 0HD.

POM

Lustral 50 mg film-coated tablets
PL 15361/0043
Lustral 100 mg film-coated tablets
PL 15361/0044

Leaflet issue and revision date (Ref.) 14.06.16[29]
Lustral® is a trademark of Pfizer Products lnc.

PATIENT INFORMATION LEAFLET

0043/0044
14.06.16[29]

Besitran™ 50 mg film-coated tablets /
Sertraline 50 mg film-coated tablets
Besitran™ 100 mg film-coated tablets /
Sertraline 100 mg film-coated tablets
(sertraline hydrochloride)
Read all of this leaflet carefully before you start taking this medicine
because it contains important information for you.
 Keep this leaflet. You may need to read it again.
 If you have any further questions, ask your doctor or pharmacist.
 This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if their symptoms are the same as
yours.
 If you get any side effects talk to your doctor or pharmacist. This
includes any possible side effects not listed in this leaflet. See section
4.
This medicine is available using any of the above names but will be
referred to as Besitran throughout this leaflet.
What is in this leaflet:
1. What Besitran is and what it is used for.
2. What you need to know before you take Besitran.
3. How to take Besitran.
4. Possible side effects.
5. How to store Besitran.
6. Contents of the pack and other information.
1. What Besitran is and what it is used for
Besitran contains the active substance sertraline. Sertraline is one of a
group of medicines called Selective Serotonin Re-uptake Inhibitors
(SSRIs); these medicines are used to treat depression and/or anxiety
disorders.
Besitran can be used to treat:
 Depression and prevention of recurrence of depression (in adults).
 Social anxiety disorder (in adults).
 Post traumatic stress disorder (PTSD) (in adults).
 Panic disorder (in adults).
 Obsessive compulsive disorder (OCD) (in adults and children and
adolescents aged 6-17 years old).
Depression is a clinical illness with symptoms like feeling sad, unable to
sleep properly or to enjoy life as you used to.
OCD and Panic disorders are illnesses linked to anxiety with symptoms
like being constantly troubled by persistent ideas (obsessions) that make
you carry out repetitive rituals (compulsions).
PTSD is a condition that can occur after a very emotionally traumatic
experience, and has some symptoms that are similar to depression and
anxiety. Social anxiety disorder (social phobia) is an illness linked to
anxiety. It is characterised by feelings of intense anxiety or distress in
social situations (for example: talking to strangers, speaking in front of
groups of people, eating or drinking in front of others or worrying that you
might behave in an embarrassing manner).
Your doctor has decided that this medicine is suitable for treating your
illness.
You should ask your doctor if you are unsure why you have been given
Besitran.
2. What you need to know before you take Besitran
Do not take Besitran:
 If you are allergic to sertraline or any of the other ingredients of this
medicine (listed in section 6).
 If you are taking or have taken medicines called monoamine oxidase
inhibitors (MAOIs such as selegiline, moclobemide) or MAOI like drugs
(such as linezolid). If you stop treatment with sertraline, you must wait
until at least one week before you start treatment with a MAOI.
After stopping treatment with a MAOI, you must wait at least 2 weeks
before you can start treatment with sertraline.
 If you are taking another medicine called pimozide (a medicine for
mental disorders such as psychosis).
Warnings and precautions
Talk to your doctor or pharmacist before taking Sertraline.
Medicines are not always suitable for everyone. Tell your doctor before
you take Besitran, if you suffer from or have suffered in the past from any
of the following conditions:
 If you have epilepsy (fit) or a history of seizures. If you have a fit
(seizure), contact your doctor immediately.
 If you have suffered from manic depressive illness (bipolar disorder) or
schizophrenia. If you have a manic episode, contact your doctor
immediately.
 If you have or have previously had thoughts of harming or killing
yourself (see below-Thoughts of suicide and worsening of your
depression or anxiety disorder).
 If you have Serotonin Syndrome. In rare cases this syndrome may
occur when you are taking certain medicines at the same time as
sertraline. (For symptoms, see section 4. Possible Side Effects). Your
doctor will have told you whether you have suffered from this in the
past.
 If you have low sodium level in your blood, since this can occur as a
result of treatment with Besitran. You should also tell your doctor if you
are taking certain medicines for hypertension, since these medicines
may also alter the sodium level in your blood.
 If you are elderly as you may be more at risk of having low sodium level
in your blood (see above).
 If you have liver disease; your doctor may decide that you should have
a lower dose of Besitran.
 If you have diabetes; your blood glucose levels may be altered due to
Besitran and your diabetes medicines may need to be adjusted.
 If you have suffered from bleeding disorders or have been taking
medicines which thin the blood (e.g. acetylsalicyclic acid (aspirin), or
warfarin) or may increase the risk of bleeding.
 If you are a child or adolescent under 18 years old.
Besitran should only be used to treat children and adolescents aged 617 years old, suffering from obsessive compulsive disorder (OCD). If
you are being treated for this disorder, your doctor will want to monitor
you closely (see below - Children and adolescents).
 If you are having electro-convulsive therapy (ECT).

 If you have eye problems, such as certain kinds of glaucoma (increased


pressure in the eye).
If you have been told that you have an abnormality of your heart tracing
after an electrocardiogram (ECG) known as prolonged QT interval.

Restlessness/Akathisia:
The use of sertraline has been linked to a distressing restlessness and
need to move, often being unable to sit or stand still (akathisia). This is
most likely to occur during the first few weeks of treatment. Increasing the
dose may be harmful so if you develop such symptoms you should talk to
your doctor.
Withdrawal reactions:
Side effects relating to stopping treatment (withdrawal reactions) are
common, particularly if the treatment is stopped suddenly (see section 3 If
you stop taking Besitran and section 4 Possible side effects). The risk of
withdrawal symptoms depends on the length of treatment, dosage, and
the rate at which the dose is reduced. Generally, such symptoms are mild
to moderate. However, they can be serious in some patients.
They normally occur within the first few days after stopping treatment. In
general, such symptoms disappear on their own and wear off within 2
weeks. In some patients they may last longer (2-3 months or more).
When stopping treatment with sertraline it is recommended to reduce the
dose gradually over a period of several weeks or months, and you should
always discuss the best way of stopping treatment with your doctor.
Thoughts of suicide and worsening of your depression or anxiety
disorder:
If you are depressed and/or have anxiety disorders you can sometimes
have thoughts of harming or killing yourself.
These may be increased when first starting antidepressants, since these
medicines all take time to work, usually about two weeks but sometimes
longer.
You may be more likely to think like this:

 If you have previously had thoughts about killing or harming yourself.
 If you are a young adult. Information from clinical trials has shown an

increased risk of suicidal behaviour in adults aged less than 25 years
with psychiatric conditions who were treated with an antidepressant.

If you have thoughts of harming or killing yourself at any time, contact
your doctor or go to a hospital straight away.
You may find it helpful to tell a relative or close friend that you are
depressed or have an anxiety disorder, and ask them to read this leaflet.
You might ask them to tell you if they think your depression or anxiety is
getting worse, or if they are worried about changes in your behaviour.
Children and adolescents:
Sertraline should not usually be used in children and adolescents less
than 18 years old, except for patients with Obsessive Compulsive
Disorder (OCD). Patients under 18 have an increased risk of undesirable
effects, such as suicide attempt, thoughts of harming or killing themselves
(suicidal thoughts) and hostility (mainly aggressiveness, oppositional
behaviour and anger) when they are treated with this class of medicines.
Nevertheless, it is possible that your doctor decides to prescribe Besitran
to a patient under 18 if it is in the patient’s interest. If your doctor has
prescribed Besitran to you and you are less than 18 years old and you
want to discuss this, please contact him/her. Furthermore, if any of the
symptoms listed above appear or worsen while you are taking Besitran,
you should inform your doctor. Also, the long-term safety of Besitran in
regard to growth, maturation and learning (cognitive) and behavioural
development in this age group has not yet been demonstrated.
Other medicines and Besitran:
Tell your doctor or pharmacist if you are taking, have recently taken or
might take any other medicines.
Some medicines can affect the way Besitran works, or Besitran itself can
reduce the effectiveness of other medicines taken at the same time.
Taking Besitran together with the following medicines may cause serious
side effects:
 Medicines called monoamine oxidase inhibitors (MAOIs), like
moclobemide (to treat depression) and selegiline (to treat Parkinson’s
disease), the antibiotic linezolid and methylene blue (to treat high levels
of methaemoglobin in the blood). Do not use Besitran together with
these medicines.
 Medicines to treat mental disorders such as psychosis (pimozide).
Do not use Besitran together with pimozide.
Talk to your doctor if you are taking the following medicines:

 Herbal medicine containing St. John’s Wort (Hypericum perforatum).
The effects of St. John’s Wort may last for 1-2 weeks.

 Products containing the amino acid tryptophan.
 Medicines to treat severe pain (e.g. tramadol).
 Medicines used in anaesthesia or to treat chronic pain (fentanyl,
mivacurium and suxamethonium).

 Medicines to treat migraines (e.g. sumatriptan).
 Blood thinning medicine (warfarin).
 Medicines to treat pain/arthritis (Non steroidal anti-inflammatory drug
(NSAID) such as ibuprofen, acetylsalicylic acid (aspirin)).

 Sedatives (diazepam).
 Diuretics (also called ‘water’ tablets).
 Medicines to treat epilepsy (phenytoin, phenobarbital, carbamazepine).
 Medicines to treat diabetes (tolbutamide).
 Medicines to treat excessive stomach acid, ulcers and heartburn










(cimetidine, omeprazole, lanzoprazole, pantoprazole, rabeprazole).
Medicines to treat mania and depression (lithium).
Other medicines to treat depression (such as amitriptyline, nortriptyline,
nefazodone, fluoxetine, fluvoxamine).
Medicines to treat schizophrenia and other mental disorders (such as
perphenazine, levomepromazine and olanzapine).
Medicines used to treat high blood pressure, chest pain or regulate the
rate and rhythm of the heart (such as verapamil, diltiazem, flecainide,
propafenone).
Medicines used to treat bacterial infections (such as rifampicin,
clarithromycin, telithromycin, erythromycin).
Medicines used to treat fungal infections (such as ketoconazole,
itraconazole, posaconazole, voriconazole, fluconazole).
Medicines used to treat HIV/AIDS and Hepatitis C (protease inhibitors
such as ritonavir, telaprevir).
Medicines used to prevent nausea and vomiting after an operation or
chemotherapy (aprepitant).
Medicines known to increase the risk of changes in the electrical activity
of the heart (e.g. some antipsychotics and antibiotics).

Besitran with food, drink and alcohol:
Besitran tablets can be taken with or without food.
Alcohol should be avoided whilst taking Besitran.
Sertraline should not be taken in combination with grapefruit juice, as this
may increase the level of sertraline in your body.
Pregnancy, breast-feeding and fertility:
If you are pregnant or breast-feeding, think you may be pregnant or are
planning to have a baby, ask your doctor or pharmacist for advice before
taking this medicine.
The safety of sertraline has not fully been established in pregnant women.
Sertraline will only be given to you when pregnant if your doctor considers
that the benefit for you is greater than any possible risk to the developing
baby. If you are a woman capable of having children you should use a
reliable method of contraception (such as the contraceptive pill), when
taking sertraline.
Make sure your midwife and/or doctor know you are on Besitran.
When taken during pregnancy, particularly in the last 3 months of
pregnancy, medicines like Besitran may increase the risk of a serious
condition in babies, called persistent pulmonary hypertension of the
newborn (PPHN), making the baby breathe faster and appear bluish.
These symptoms usually begin during the first 24 hours after the baby is
born. If this happens to your baby you should contact your midwife and/or
doctor immediately.
Your newborn baby might also have other conditions, which usually begin
during the first 24 hours after birth. Symptoms include:
 trouble with breathing,
 a blueish skin or being too hot or cold,
 blue lips,
 vomiting or not feeding properly,
 being very tired, not able to sleep or crying a lot,
 stiff or floppy muscles,
 tremors, jitters or fits,
 increased reflex reactions,
 irritability,
 low blood sugar.
If your baby has any of these symptoms when it is born, or you are
concerned about your baby’s health, contact your doctor or midwife who
will be able to advise you.
There is evidence that sertraline passes into human breast milk.
Sertraline should only be used in women during breast-feeding, if your
doctor considers that the benefit exceeds any possible risk to the baby.
Some medicines like sertraline may reduce the quality of sperm in animal
studies. Theoretically, this could affect fertility, but impact on human
fertility has not been observed as yet.
Driving and using machines:
Psychotropic drugs such as sertraline may influence your ability to drive or
use machines. You should therefore not drive or operate machinery, until
you know how this medication affects your ability to perform these activities.
3. How to take Besitran
Always take this medicine exactly as your doctor or pharmacist has told
you.
Check with your doctor or pharmacist if you are not sure.
The recommended dose is:
Adults:
Depression and Obsessive Compulsive Disorder
For depression and OCD, the usual effective dose is 50 mg/day. The
daily dose may be increased in 50 mg increments and at intervals of at
least one week over a period of weeks. The maximum recommended
dose is 200 mg/day.
Panic disorder, Social anxiety disorder and Post Traumatic Stress
Disorder:
For panic disorder, social anxiety disorder and post traumatic stress
disorder, treatment should be started at 25 mg/day, and increased to 50
mg/day after one week.
The daily dose then may be increased in 50 mg increments over a
period of weeks. The maximum recommended dose is 200 mg/day.
Use in children and adolescents:
Besitran must only be used to treat children and adolescents suffering
from OCD aged 6-17 years old.
Obsessive Compulsive Disorder:
Children aged 6 to 12: the recommended starting dose is 25 mg daily.
After one week, your doctor may increase this to 50 mg daily. The
maximum dose is 200 mg daily.
Adolescents aged 13 to 17: the recommended starting dose is 50 mg
daily.
The maximum dose is 200 mg daily.
If you have liver or kidney problems, please tell your doctor and follow the
doctor’s instructions.
Method of administration:
Besitran tablets may be taken with or without food.
Take your medication once daily either in the morning or evening.
Your doctor will advise you on how long to take this medication for. This
will depend on the nature of your illness and how well you are responding
to the treatment. It may take several weeks before your symptoms begin
to improve. Treatment of depression should usually continue for 6 months
after improvement.
If you take more Besitran than you should:
If you accidentally take too much Besitran contact your doctor at once or
go to the nearest hospital casualty department.
Always take the labelled medicine package with you, whether there is any
medication left or not.
Symptoms of overdose may include drowsiness, nausea and vomiting,
rapid heart rate, shaking, agitation, dizziness and in rare cases
unconsciousness.
If you forget to take Besitran:
Do not take a double dose to make up for a forgotten dose. If you forget
to take a dose, do not take the missed dose. Just take the next dose at
the right time.

If you stop taking Besitran:
Do not stop taking Besitran unless your doctor tells you to.
Your doctor will want to gradually reduce your dose of Besitran over
several weeks, before you finally stop taking this medicine. If you
suddenly stop taking this medicine you may experience side effects such
as dizziness, numbness, sleep disturbances, agitation or anxiety,
headaches, feeling sick, being sick and shaking. If you experience any of
these side effects, or any other side effects whilst stopping taking
Besitran, please speak to your doctor.
If you have any further questions on the use of this product, ask your
doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not
everybody gets them.
Nausea is the most common side effect. The side effects depend on the
dose and often disappear or lessen with continued treatment.
Tell your doctor immediately:
If you experience any of the following symptoms after taking this
medicine, these symptoms can be serious.
 If you develop a severe skin rash that causes blistering (erythema
multiforme), (this can affect the mouth and tongue). These may be
signs of a condition known as Stevens Johnson Syndrome, or Toxic
Epidermal Necrolysis (TEN). Your doctor will stop your treatment in
these cases.
 Allergic reaction or allergy, which may include symptoms such as an itchy
skin rash, breathing problems, wheezing, swollen eyelids, face or lips.
 If you experience agitation, confusion, diarrhoea, high temperature and
blood pressure, excessive sweating and rapid heartbeat. These are
symptoms of Serotonin Syndrome. In rare cases this syndrome may
occur when you are taking certain medicines at the same time as
sertraline. Your doctor may wish to stop your treatment.
 If you develop yellow skin and eyes which may mean liver damage.
 If you experience depressive symptoms with ideas of harming or killing
yourself (suicidal thoughts).
 If you start to get feelings of restlessness and are not able to sit or
stand still after you start to take Besitran.
You should tell your doctor if you start to feel restless.
 If you have a fit (seizure).
 If you have a manic episode (see section 2 “Warnings and
precautions”).
The following side effects were seen in clinical trials in adults.
Very common (may affect more than 1 in 10 people):
Insomnia, dizziness, sleepiness, headache, diarrhoea, feeling sick, dry
mouth, ejaculation failure, fatigue.
Common side effects (may affect up to 1 in 10 people):

 Sore throat, anorexia, increased appetite,
 depression, feeling strange, nightmare, anxiety, agitation, nervousness,
decreased sexual interest, teeth grinding,

 numbness and tingling, shaking, muscle tense, abnormal taste, lack of







attention,
visual disturbance, ringing in ears,
palpitations, hot flush, yawning,
abdominal pain, vomiting, constipation, upset stomach, gas,
rash, increased sweating, muscle pain, sexual dysfunction, erectile
dysfunction, chest pain.
joint pain,
malaise.

Uncommon (may affect up to 1 in 100 people):

 Cases of suicidal ideation and suicidal behaviours have been
reported during sertraline therapy or early after treatment
discontinuation (see section 2.).

After marketing sertraline, the following side effects have been
reported:
 Decrease in white blood cells, decrease in clotting cells, endocrine
problem, low blood salt, increase in blood sugar levels,
 terrifying abnormal dreams, suicidal behaviour,
 muscular movement problems (such as moving a lot, tense muscles,
difficulty walking and stiffness, spasms and involuntary movements of
muscles), sudden severe headache (which may be a sign of a serious
condition known as Reversible Cerebral Vasoconstriction Syndrome
(RCVS)),
 vision abnormal, unequal sized pupils, bleeding problems (such as
stomach bleeding), progressive scarring of lung tissue (Interstitial Lung
Disease), pancreatitis, serious liver function problems, yellow skin and
eyes (jaundice),
 skin oedema, skin reaction to sun, muscle cramps, breast enlargement,
problems with clotting, abnormal laboratory tests, bedwetting.
 Light-headedness, fainting, or chest discomfort which could be signs of
changes in the electrical activity (seen on electrocardiogram) or
abnormal rhythm of the heart.
Additional side effects in children and adolescents
In clinical trials with children and adolescents, the side effects were
generally similar to adults (see above). The most common side effects in
children and adolescents were headache, insomnia, diarrhoea and feeling
sick.
Symptoms that can occur when treatment is discontinued
If you suddenly stop taking this medicine you may experience side effects
such as dizziness, numbness, sleep disturbances, agitation or anxiety,
headaches, feeling sick, being sick and shaking (see section 3. “If you
stop taking Besitran”).
An increased risk of bone fractures has been observed in patients taking
this type of medicines.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This
includes any possible side effects not listed in this leaflet. You can also
report side effects directly via the Yellow Card Scheme at:
www.mhra.gov.uk/yellowcard.
By reporting side effects, you can help provide more information on the
safety of this medicine.
5. How to store Besitran
Keep out of the sight and reach of children.
Do not store above 30oC.
Do not use Besitran after the expiry date which is stated on the pack. The
expiry date refers to the last day of that month.
Medicines should not be disposed of via wastewater or household waste.
Ask your pharmacist how to dispose of medicines no longer required.
These measures will help to protect the environment.
6. Contents of the pack and other information
What Besitran contains
The active substance is sertraline hydrochloride.
Besitran 50mg film-coated tablets contains 50mg of sertraline
(as hydrochloride)
Besitran 100mg film-coated tablets contains 100mg of sertraline
(as hydrochloride)
Other ingredients: calcium hydrogen phosphate, hydroxypropylcellulose,
hydroxypropylmethylcellulose, magnesium stearate, microcrystalline
cellulose, polyethylene glycol, polysorbate-80, sodium starch glycollate,
and titanium dioxide.

 Chest cold, runny nose,
 hypersensitivity,
 low thyroid hormones,
 hallucination, feeling too happy, lack of caring, thinking abnormal,

What Besitran looks like and contents of the pack
Besitran 50 mg film-coated tablets are white capsular shaped with the
markings “ZLT” AND “50” on one side and “Pfizer” on the other side.
Besitran 100 mg film-coated tablets are white capsular shaped with the
markings “ZLT” AND “100” on one side and “Pfizer” on the other side.

 convulsion, involuntary muscle contractions, abnormal coordination,

Each pack contains 30 tablets.

aggression,










moving a lot, amnesia, decreased feeling, speech disorder, dizziness
while standing up, passing out, migraine,
enlarged pupils,
ear pain, fast heartbeat, high blood pressure, flushing,
breathing difficulty, possible wheezing, shortness of breath, nose bleed,
inflammation of the oesophagus, difficulty swallowing, haemorrhoids,
increased saliva, tongue disorder, burping,
eye swelling, purple spots on skin, face oedema, hair loss, cold sweat,
dry skin, hives, itching,
osteoarthritis, muscular weakness, back pain, muscle twitching,
nighttime urination, unable to urinate, increase in urination, increase in
frequency of urination, problem urinating, urinary incontinence,
vaginal haemorrhage, sexual dysfunction, female sexual dysfunction,
menstrual irregularities, swelling in legs, chills, fever, weakness, thirst,
increase in liver enzyme levels, weight decreased, weight increased.

Manufacturer and Product Licence Holder
Manufactured by Farmasierra Manufacturing S.L., San Sebastian de los
Reyes, Madrid, Spain. Procured from within the EU and Repackaged by
the Product Licence holder P.I.E. Pharma Ltd, 207 Kenton Road, Harrow,
Middlesex HA3 0HD.
POM
Besitran 50 mg film-coated tablets /
Sertraline 50 mg film-coated tablets
PL 15361/0043
Besitran 100 mg film-coated tablets /
Sertraline 100 mg film-coated tablets
PL 15361/0044

Rare (may affect up to 1 in 1,000 people):

 Intestine problem, ear infection, cancer, swollen glands, high

Leaflet issue and revision date (Ref.) 14.06.16[29]



Besitran is a trademark of Pfizer Products lnc.












cholesterol, low blood sugar,
physical symptoms due to stress or emotions, drug dependence,
psychotic disorder, paranoia, suicidal thoughts, sleep walking,
premature ejaculation,
severe allergic reaction,
coma, abnormal movements, difficulty moving, increased sensation,
sensory disturbance,
glaucoma, tear problem, spots in front of eyes, double vision, light hurts
eye, blood in the eye,
problems controlling blood sugar levels (diabetes),
heart attack, slow heart beat, heart problem, poor circulation of arms
and legs, closing up of throat, breathing fast, breathing slow, difficulty
talking, hiccups,
blood in stool, sore mouth, tongue ulceration, tooth disorder, tongue
problem, mouth ulceration, problems with liver function,
skin problem with blisters, hair rash, hair texture abnormal, skin odour
abnormal, bone disorder,
decreased urination, urinary hesitation, blood in urine,
excessive vaginal bleeding, dry vaginal area, red painful penis and
foreskin, genital discharge, prolonged erection, breast discharge,
hernia, drug tolerance decreased, difficulty walking, semen abnormal,
increase in blood cholesterol levels, injury, relaxation of blood vessels
procedure.

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide